Citation tools
"Correction to “Rimonabant, a Cannabinoid Receptor Type 1 Inverse Agonist, Inhibits Hepatocyte Lipogenesis by Activating Liver Kinase B1 and AMP-Activated Protein Kinase Axis Downstream of Gαi/o Inhibition”." Molecular Pharmacology
82.3
(2012):
561-562.
Web. 26 Sept2023.